Request Demo
Last update 22 Sep 2026
Meropenem/pribactam
Last update 22 Sep 2026
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms 美罗培南普纳巴坦 |
Target |
Action inhibitors |
Mechanism PBPs inhibitors(Bacterial penicillin-binding protein inhibitors) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseNDA/BLA |
First Approval Date- |
Regulation- |
Login to view timeline
Related
4
Clinical Trials associated with Meropenem/pribactamCTR20255177
评价注射用美罗培南普莱巴坦与注射用头孢他啶阿维巴坦钠相比治疗医院获得性细菌性肺炎 /呼吸机相关性细菌性肺炎有效性和安全性的多中心、随机、双盲、平行对照的 Ⅲ期临床研究
[Translation] A multicenter, randomized, double-blind, parallel-controlled phase III clinical trial evaluating the efficacy and safety of meropenem/prebactam for injection compared to ceftazidime/avibactam sodium for injection in the treatment of hospital-acquired bacterial pneumonia/ventilator-associated bacterial pneumonia.
CTR20253255
评价注射用美罗培南普莱巴坦在中国成人健康参与者支气管肺上皮衬液药物浓度及渗透性的单中心、随机、开放的I期临床研究
[Translation] A single-center, randomized, open-label phase I clinical study to evaluate the drug concentration and permeability of meropenem-prelebactam for injection in the bronchopulmonary epithelial lining fluid of healthy Chinese adult participants
NCT07089186
A Phase 3, Multicenter, Randomized, Open-label, Active-controlled, Parallel-design Clinical Study to Evaluate the Efficacy and Safety of Meropenem and Pralubactam for Injection in the Treatment of Carbapenem-Resistant Enterobacteriaceae Infections
100 Clinical Results associated with Meropenem/pribactam
Login to view more data
100 Translational Medicine associated with Meropenem/pribactam
Login to view more data
100 Patents (Medical) associated with Meropenem/pribactam
Login to view more data
100 Deals associated with Meropenem/pribactam
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Complicated intra-abdominal infection | NDA/BLA | China | 15 Sep 2026 | |
| Complicated urinary tract infection | Phase 3 | China | 12 Apr 2025 | |
| Enterobacteriaceae Infections | Phase 3 | China | 12 Apr 2025 | |
| Hospital acquired bacterial pneumonia | Phase 3 | China | 12 Apr 2025 | |
| Sepsis | Phase 3 | China | 12 Apr 2025 | |
| Ventilator associated bacterial pneumonia | Phase 3 | China | 12 Apr 2025 | |
| Carbapenem Resistant Bacterial Infection | Phase 3 | China | 08 Nov 2024 | |
| Carbapenem Resistant Bacterial Infection | Phase 3 | China | 08 Nov 2024 | |
| Intraabdominal Infections | Phase 3 | China | 31 Oct 2024 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free